4-AMINO-5-CHLORO-1,2,3-BENZOTHIADIAZOLE

We are 4-AMINO-5-CHLORO-1,2,3-BENZOTHIADIAZOLE CAS:115398-34-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 4-AMINO-5-CHLORO-1,2,3-BENZOTHIADIAZOLE
CAS.NO:115398-34-0
Synonyms:
4-AMINO-5-CHLORO-2,1,3-BENZOTHIADIAZOLE
4-AMINO-5-CHLOROPIAZTHIOLE
5-Chloro 2,1,3 Benzothidiazole 4 Amine
5-CHLORO-BENZO[1,2,5]THIADIAZOL-4-YLAMINE
5 CHLORO 4 AMINO-2,1,3,BENZOTHIADIAZOLE

Molecular Formula: C6H4ClN3S
Molecular Weight:185.63400

Physical and Chemical Properties:
Density: /
Boiling point: /
Melting point:89ºC
Flash point: /
Refractive index: 1.782

Specification:
Appearance:white crystalline powder
Purity:≥99%
Moisture Content: ≤0.1%
Impurity: ≤0.5%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Tizanidine hydrochloride CAS:64461-82-1

Related News: Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the global pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules.6-metilpiridin-2-amina CAS:1824-81-3 Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the global pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules.886230-75-7 FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus.381-98-6 Beneficial drug raw materials refer to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs). They are mainly used to meet the needs of original multinational pharmaceutical companies and emerging biopharmaceutical companies for innovative drugs in clinical drug research, registration approval and commercialization sales , Which also contains advanced intermediates used in the manufacture of the drug substance that need to be regulated by regulatory authorities.Combining its core technological advantages such as ammonia oxidation, phosgenation, and fluorination, the company actively enters the field of fine and functional chemicals, and expands its focus to include polymer additives, replacement of phenolic polymer material monomers, and coating preservatives.